Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 7,7'-Bis(diphenylphosphino)-4,4'-dimethyl-3,3',4,4'-tetrahydro-2H ,2'H-8,8'-bi-1,4-benzoxazine

7,7'-Bis(diphenylphosphino)-4,4'-dimethyl-3,3',4,4'-tetrahydro-2H ,2'H-8,8'-bi-1,4-benzoxazine

7,7'-Bis(diphenylphosphino)-4,4'-dimethyl-3,3',4,4'-tetrahydro-2H ,2'H-8,8'-bi-1,4-benzoxazine structure

7,7'-Bis(diphenylphosphino)-4,4'-dimethyl-3,3',4,4'-tetrahydro-2H ,2'H-8,8'-bi-1,4-benzoxazine 

structure
  • CAS No:

    649559-68-2

  • Formula:

    C42H38N2O2P2

  • Chemical Name:

    7,7'-Bis(diphenylphosphino)-4,4'-dimethyl-3,3',4,4'-tetrahydro-2H ,2'H-8,8'-bi-1,4-benzoxazine

  • Synonyms:

    S-(-)-N,N'-DIMETHYL-7,7'-BIS(DIPHENYLPHOSPHINO)-3,3',4,4'-TETRAHYDRO-8,8'-BI-2H-1,4-BENZOXAZINE; (R)-7,7'-BIS[DI(3,5-XYLYL)PHOSPHINO]-3,3',4,4'-TETRAHYDRO-4,4'-DIMETHYL-8,8'-BI(2H-1,4-BENZOXAZINE); (R)-7,7'-BIS(DIPHENYLPHOSPHINO)-3,3',4,4'-TETRAHYDRO-4,4'-DIMETHYL-8,8'-BI(2H-1,4-BENZOXAZINE); SOLPHOS SL-A001-1; (S)-7,7'-BIS(DIPHENYLPHOSPHINO)-3,3',4,4'-TETRAHYDRO-4,4'-DIMETHYL-8,8'-BI(2H-1,4-BENZOXAZINE); XYLYL-SOLPHOS SL-A002-1; R-SOLPHOS; (R)-7,7'-Bis(diphenylphosphino)-3,3',4,4'-tetrahydro-4,4'-dimethyl-8,8'-bi(2H-1; Solvias BINAP; S-SOLPHOS;Expand

7,7'-Bis(diphenylphosphino)-4,4'-dimethyl-3,3',4,4'-tetrahydro-2H ,2'H-8,8'-bi-1,4-benzoxazine Basic Attributes

664.71100

664.24085245

Characteristics

52.12000

6.65720

Safety Information

UN 2811 6.1/PG 3

R22

Xn

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory.

Computed Properties

Molecular Weight:664.7
XLogP3:8.7
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:7
Exact Mass:664.24085245
Monoisotopic Mass:664.24085245
Topological Polar Surface Area:24.9
Heavy Atom Count:48
Complexity:878
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Guide of 7,7'-Bis(diphenylphosphino)-4,4'-dimethyl-3,3',4,4'-tetrahydro-2H ,2'H-8,8'-bi-1,4-benzoxazine

Request for Quotation

Share

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.